Figure 2From: Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole Levels of proliferation-associated genes before (pre) and after treatment with Letrozole (10 to 14 days).Back to article page